Medication Name

Evista (generic name: raloxifene) is a medication used primarily for the treatment and prevention of osteoporosis in postmenopausal women. It is classified under selective estrogen receptor modulators (SERMs).

Mechanism of Action

Evista works by mimicking the effects of estrogen on bone, thus increasing bone density. This action helps to reduce the risk of bone fractures in postmenopausal women. However, it does not mimic estrogen’s effects on the uterus and breast tissue, reducing the risk of side effects in these areas.

Indications and Usage

Evista is indicated for the prevention and treatment of osteoporosis in postmenopausal women. It is also used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or those at high risk for invasive breast cancer.

Dosage and Administration

The recommended dosage of Evista is 60 mg once daily, with or without food. It should be taken at the same time each day to maintain consistent blood levels. It is important to follow the prescribed dosage regimen and not to adjust the dose without consulting a healthcare provider.

Missed Dose Instructions

If a dose is missed, take it as soon as remembered. If it is almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not take two doses at the same time to make up for a missed one.

Storage Conditions

Evista should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). Keep the medication in its original container, tightly closed, and away from excess heat and moisture. Do not store it in the bathroom. Keep out of reach of children and pets.

Potential Side Effects

Common side effects of Evista may include hot flashes, leg cramps, swelling of the legs and feet, flu-like symptoms, joint pain, and sweating. Contact a healthcare provider if any side effects persist or worsen.

Drug Interactions

Evista may interact with other medications, including anticoagulants, cholestyramine, and thyroid hormones. Inform the healthcare provider of all medications, supplements, and herbal products currently being taken to avoid potential interactions.

Contraindications and Precautions

Evista is contraindicated in patients with a history of venous thromboembolic events, including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis. Use with caution in patients with liver disease, kidney disease, or a history of stroke.

Pregnancy and Nursing

Evista is contraindicated during pregnancy due to potential harm to the fetus. Women of childbearing potential should use effective contraception while taking Evista. It is not recommended for use in nursing mothers as it is unknown whether raloxifene is excreted in human milk.

Monitoring Parameters

Patients on Evista should have periodic bone density assessments, liver function tests, and lipid profiles. Regular check-ups with a healthcare provider are necessary to monitor the effectiveness and any potential adverse effects of the medication.

Patient Counseling Information

Patients should be informed about the potential benefits and risks of Evista. Emphasize the importance of adherence to prescribed therapy, lifestyle changes inclusive of diet, exercise, and smoking cessation, and the need for routine medical follow-ups.